A pilot study by Mandel et al. demonstrated the effectiveness of B. coagulans on RA symptoms using clinical examination and laboratory tests for erythrocyte sedimentation rate and C-reactive protein. The gene discussed is CRP; the disease is rheumatoid arthritis.